---
title: "Biggest stock movers Thursday: NVDA, OKTA, MRNA, and more"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297202579.md"
description: "Biggest stock movers Thursday: NVDA, OKTA, MRNA, and more"
datetime: "2026-08-27T14:31:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297202579.md)
  - [en](https://longbridge.com/en/news/297202579.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297202579.md)
generator: "portal-rs"
---

# Biggest stock movers Thursday: NVDA, OKTA, MRNA, and more


### Related Stocks

- [OKTA.US](https://longbridge.com/en/quote/OKTA.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [OKTX.US](https://longbridge.com/en/quote/OKTX.US.md)
- [MRNX.US](https://longbridge.com/en/quote/MRNX.US.md)
- [MRNY.US](https://longbridge.com/en/quote/MRNY.US.md)

## Related News & Research

- [Nvidia (NVDA) Earns Price-Target Upgrades After Monster Q2](https://longbridge.com/en/news/297214744.md)
- [NVIDIA Beat Revenue and Guided to $108B - Can NVDA Hold Its Post-Earnings Breakout?](https://longbridge.com/en/news/297182320.md)
- [Moderna Stock (MRNA) Slides 3% on Plans for a $2B Private Placement](https://longbridge.com/en/news/297195128.md)
- [Wolfe Research Just Upgraded Moderna Stock. Here's Why.](https://longbridge.com/en/news/296951590.md)
- [Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.](https://longbridge.com/en/news/296643850.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**